Table 8.
LH Prevalence in Patients with Different Diabetes Duration and Time of Insulin Use
| Author (Year) | Duration of Diabetes | P-value | Duration of Insulin Use | P-value | ||||
|---|---|---|---|---|---|---|---|---|
| ≤5 | 6–10 | >10 | ≤5 | 6–10 | >10 | |||
| Lin et al (2021)19 | 26/28 (48.15%) | 29/8 (78.38%) | 28/1 (96.55%) | <0.0001 | ||||
| Arora et al (2021)20 | 83/99 (45.6%) | 115/63 (64.61%) | 92/48 (65.71%) | <0.0001 | 224/179 (55.58%) | 46/21 (68.66%) | 20/10 (66.67%) | <0.0001 |
| Gentile et al (2021)21 | 20 ± 11 | 221/311 (41.54%) | 58/65 (47.15%) | 81/44 (64.8%) | <0.0001 | |||
| Thewjitcharoen et al (2020)22 | 24.1 ± 8.9 | 13.4 ± 9.2 | ||||||
| Gentile et al (2020)12 | 12 ± 9 | 12 ± 5 | ||||||
| Lian et al (2018)23 | 10.98 ± 3.12 | 4.47±1.93 | ||||||
| Tsadik et al (2018)24 | 65/46 (58.56%) | 38/27 (58.46%) | >0.05 | |||||
| Hernar et al (2017)17 | 17.0 (1–57) | |||||||
| Al Hayek et al (2016)25 | 38/68 (35.85%) | 45/23 (66.18%) | <0.0001 | |||||
| Sawatkar et al (2014)26 | 4.43 ± 4.4 | |||||||